For your information a link I received on a stem cell therapy for RD.

Guildford, England, April 4, 2006: ReNeuron Group plc (LSE: RENE.L) today
announces initial survival efficacy data with its ReN003 stem cell therapy
programme for diseases of the retina. The joint research, led by Professors
John Greenwood and Stephen Moss at the UCL Institute of Ophthalmology in
London, showed expansion of human retinal progenitor cells with markers of
photoreceptors over multiple population doublings. These progenitors showed
an ability to engraft and protect the photoreceptor layer of the retina from
degeneration in a retinal dystrophic model

-----Ursprüngliche Nachricht-----
Von: se.klaes@... [mailto:se.klaes@...]
Gesendet: Mittwoch, 5. April 2006 00:58
An: Markus Georg
Betreff: (kein Betreff)

http://www.medadnews.com/News/Index.cfm?articleid=328415